Similar articles

• Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.

  van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH. van der Linden MP, et al. Arthritis Rheum. 2009 Aug;60(8):2232-41. doi: 10.1002/art.24716. Arthritis Rheum. 2009. PMID: 19644872
• Review: anti-cyclic citrullinated peptide antibody is a more specific test for rheumatoid arthritis than rheumatoid factor.

  Schattner A. Schattner A. Evid Based Med. 2007 Dec;12(6):183. doi: 10.1136/ebm.12.6.183. Evid Based Med. 2007. PMID: 18063743 No abstract available.
• IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.

  Vis M, Bos WH, Wolbink G, Voskuyl AE, Twisk JW, Van de Stadt R, Hamann D, Dijkmans BA, Lems WF. Vis M, et al. J Rheumatol. 2008 Mar;35(3):425-8. J Rheumatol. 2008. PMID: 18322974
• Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: a review.

  Lee AN, Beck CE, Hall M. Lee AN, et al. Clin Lab Sci. 2008 Winter;21(1):15-8. Clin Lab Sci. 2008. PMID: 18335856 Review.
• Antibodies to citrullinated proteins in arthritis: pathology and promise.

  Klareskog L, Widhe M, Hermansson M, Rönnelid J. Klareskog L, et al. Curr Opin Rheumatol. 2008 May;20(3):300-5. doi: 10.1097/BOR.0b013e3282fbd22a. Curr Opin Rheumatol. 2008. PMID: 18388522 Review.